Primary small cell neuroendocrine carcinoma of the larynx. Two case reports.
Two cases of primary small cell neuroendocrine carcinoma of the larynx (SCNLC) are presented. One patient is alive at 5 years without evidence of disease, after the combined therapy (surgery, radiotherapy and chemotherapy), the either treated without adjuvant chemotherapy died at 22 months because of lung and liver metastases.
Center of Oncology, Maria Sklodowska-Curie Memorial Institute, Kraków, Poland.
M
M
Reinfuss
T
T
Kowalska
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018278:Carcinoma, Neuroendocrine / Q000473:pathology / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology / Q000628:therapy*; D007825:Laryngectomy; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage